Advanced search
Publication Cover
Leukemia & Lymphoma Volume 44, 2003 - Issue 4
Submit an article Journal homepage
17
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Remission of Follicular Non-Hodgkin's Lymphoma with Denileukin Diftitox (ONTAK ® ) After Progression During Rituximab, CHOP and Fludarabine Therapy

Barton R. Paschal Asheville Hematology & Oncology Associates, P.A., One Doctors Drive, Asheville, NC 28801, USA
Pages 731-733 | Published online: 01 Jul 2009

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Timothy M. Kuzel, Shuli Li, John Eklund, Francine Foss, Randy Gascoyne, Neil Abramson, John F. Schwerkoske, Edie Weller & Sandra J. Horning. (2007) Phase II study of denileukin diftitox for previously treated indolent non-Hodgkin lymphoma: Final results of E1497. Leukemia & Lymphoma 48:12, pages 2397-2402.
Read now
Bryan Y. Wong, Stephanie A. Gregory & Nam H. Dang. (2007) Denileukin Diftitox as Novel Targeted Therapy for Lymphoid Malignancies. Cancer Investigation 25:6, pages 495-501.
Read now

Articles from other publishers (5)

Daniel J. Powell, Peter Attia, Victor Ghetie, John Schindler, Ellen S. Vitetta & Steven A. Rosenberg. (2008) Partial Reduction of Human FOXP3+ CD4 T Cells In Vivo After CD25-directed Recombinant Immunotoxin Administration. Journal of Immunotherapy 31:2, pages 189-198.
Crossref
A. Shankar & Vaskar Saha. 2006. The Lymphomas. The Lymphomas 502 525 .
Peter Attia, Ajay V Maker, Leah R Haworth, Linda Rogers-Freezer & Steven A Rosenberg. (2005) Inability of a Fusion Protein of IL-2 and Diphtheria Toxin (Denileukin Diftitox, DAB389IL-2, ONTAK) to Eliminate Regulatory T Lymphocytes in Patients With Melanoma. Journal of Immunotherapy 28:6, pages 582-592.
Crossref
Nam H. Dang, Fredrick B. Hagemeister, Barbara Pro, Peter McLaughlin, Jorge E. Romaguera, Dan Jones, Barry Samuels, Felipe Samaniego, Anas Younes, Michael Wang, Andre Goy, Maria A. Rodriguez, Pamela L. Walker, Yolanda Arredondo, Ann T. Tong & Luis Fayad. (2004) Phase II Study of Denileukin Diftitox for Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma. Journal of Clinical Oncology 22:20, pages 4095-4102.
Crossref
. (2003) Current Awareness in Hematological Oncology. Hematological Oncology 21:3, pages 141-148.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.